Choline is an essential nutrient required for hepatic lipid handling through its role in phosphatidylcholine synthesis, which is necessary for assembling and secreting very low–density lipoprotein VLDL particles that export triglycerides from the liver. Clinical and experimental work by Steven H. Zeisel University of North Carolina demonstrates that inadequate choline intake can impair VLDL secretion and promote hepatic triglyceride accumulation, producing steatosis even in otherwise healthy individuals. The National Institutes of Health Office of Dietary Supplements recognizes choline as a conditionally essential nutrient and discusses the implications of low intake for liver health.
Biological mechanisms and causes
At the biochemical level, insufficient phosphatidylcholine reduces the liver’s capacity to package and export lipids, which leads to intracellular lipid droplets and fatty liver. Methylation pathways that use choline-derived betaine also influence homocysteine metabolism and gene expression relevant to lipid metabolism. Genetic variation in enzymes such as PEMT and in one-carbon metabolism modifies choline requirements, a relationship explored in studies by Steven H. Zeisel University of North Carolina showing some people need more dietary choline to avoid steatosis.
Consequences and broader relevance
Hepatic fat accumulation from choline deficiency can progress to inflammation, fibrosis, and contribute to nonalcoholic fatty liver disease NAFLD, especially when combined with obesity, insulin resistance, or alcohol use. Public health implications vary by diet and culture: populations with diets low in animal-source foods, including some vegetarian and vegan groups, may have lower choline intake, while regional dietary patterns that rely on eggs, organ meats, and soy provide higher choline. Pregnancy increases choline demand, affecting both maternal liver status and fetal development, a nuance relevant to maternal-child health programs.
Gut microbial conversion of choline to trimethylamine and subsequent formation of Trimethylamine N-oxide TMAO links choline metabolism to cardiovascular research; work by Stanley L. Hazen Cleveland Clinic shows TMAO associations with atherosclerotic risk, creating a complex trade-off between choline’s hepatic benefits and potential cardiometabolic pathways. Clinically, assessing dietary intake, genetic risk factors, and metabolic status helps determine whether dietary adjustment or targeted supplementation is appropriate to prevent liver fat accumulation while considering broader health outcomes.